Recombinant multi-species ARTN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ARTN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a secreted ligand of the glial cell line-derived neurotrophic factor (GDNF) subfamily and TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein signals through the RET receptor and GFR alpha 3 coreceptor, and supports the survival of a number of peripheral neuron populations and at least one population of dopaminergic CNS neurons. This protein has also been shown to promote tumor growth, metastasis, and drug resistance in mammary carcinoma. [provided by RefSeq, Aug 2016]
The Alternative Names of target: ART,ARTN,Artemin,Artn,ENOVIN,EVN,Enovin,NBN,Neublastin,neublastin

Target products collectionGo to ARTN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0680-Ag-1/ GM-Tg-hg-SE0680-Ag-2 Human ARTN protein Human
GM-Tg-rg-SE0680-Ag-1/ GM-Tg-rg-SE0680-Ag-2 Rat ARTN protein Rat
GM-Tg-mg-SE0680-Ag-1/ GM-Tg-mg-SE0680-Ag-2 Mouse ARTN protein Mouse
GM-Tg-cynog-SE0680-Ag-1/ GM-Tg-cynog-SE0680-Ag-2 Cynomolgus/Rhesus macaque ARTN protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0680-Ag-1/ GM-Tg-felg-SE0680-Ag-2 Feline ARTN protein Feline
GM-Tg-cang-SE0680-Ag-1/ GM-Tg-cang-SE0680-Ag-2 Canine ARTN protein Canine
GM-Tg-bovg-SE0680-Ag-1/ GM-Tg-bovg-SE0680-Ag-2 Bovine ARTN protein Bovine
GM-Tg-equg-SE0680-Ag-1/ GM-Tg-equg-SE0680-Ag-2 Equine ARTN protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0680-Ag-1/ GM-Tg-hg-SE0680-Ag-2; GM-Tg-rg-SE0680-Ag-1/ GM-Tg-rg-SE0680-Ag-2;
GM-Tg-mg-SE0680-Ag-1/ GM-Tg-mg-SE0680-Ag-2; GM-Tg-cynog-SE0680-Ag-1/ GM-Tg-cynog-SE0680-Ag-2;
GM-Tg-felg-SE0680-Ag-1/ GM-Tg-felg-SE0680-Ag-2; GM-Tg-cang-SE0680-Ag-1/ GM-Tg-cang-SE0680-Ag-2;
GM-Tg-bovg-SE0680-Ag-1/ GM-Tg-bovg-SE0680-Ag-2; GM-Tg-equg-SE0680-Ag-1/ GM-Tg-equg-SE0680-Ag-2
Products Name ARTN protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ARTN
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ARTN protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.